PM
SGMO

Parametrica Management’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Parametrica Management’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-10,442
Closed -$159K – 96
2014
Q2 		$159K Buy
+10,442
New +$150K 1.2% 49

Other funds holding SGMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Parametrica Management's SGMO Position: Q3 2014 in Review

Parametrica Management sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q3 2014, closing a stake of 10,442 shares — an estimated $159K sold.

Parametrica Management first reported a position in SGMO in Q2 2014 and held it in 1 quarter. The position peaked at $159K in Q2 2014. 157 funds tracked by Wall St. Rank hold SGMO as of Q3 2014.

  • Parametrica Management reported no remaining SANGAMO THERAPEUTICS INC position as of Q3 2014 after selling out during the quarter.
  • Parametrica Management sold 10,442 SANGAMO THERAPEUTICS INC shares in Q3 2014, an estimated $159K.
  • Parametrica Management first reported a position in SANGAMO THERAPEUTICS INC in Q2 2014 and held it in 1 quarter.
  • Parametrica Management's SANGAMO THERAPEUTICS INC position peaked at $159K in Q2 2014.
  • 157 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q3 2014.

Based on Parametrica Management's 13F filing for Q3 2014, filed 28 Oct 2014.